Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Thermo Fisher Scientific : FBI Approves Thermo Fisher Scientific Forensic Sequencing Solution for National DNA Index System

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/09/2019 | 08:18am EDT

FBI Approves Thermo Fisher Scientific Forensic Sequencing Solution for National DNA Index System

Decision enables human identification labs to upload genetic profiles to national database using Applied Biosystems Precision ID panel for mitochondrial DNA analysis

SAN FRANCISCO, July 9, 2019/PRNewswire / -- The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific's Applied Biosystems Precision ID System mtDNA analysis solution for use by forensic laboratories to generate mitochondrial DNA (mtDNA) profiles for submission to the U.S. National DNA Index System (NDIS) CODIS database. The use of mtDNA in forensics over the past several decades has played a pivotal role in helping to solve missing person cases and identification of remains recovered from mass disasters.

Due to its high copy number per cell, mtDNA is the primary testing method for forensic laboratories that routinely analyze extremely challenging samples, such as decades-old bone fragments, teeth and other human remains. While the methodology has proven useful to help close missing person cases, for example, profiles derived from next-generation sequencing (NGS)-based platforms could not be uploaded to the national database until recently. Approval of the panel now provides laboratories with the ability to analyze the most challenging missing persons and criminal casework samples while providing the greatest level of discrimination through whole mtDNA genome analysis.

The Precision ID mtDNA Whole Genome Panel is part of a NGS-based system that includes the Ion GeneStudio S5 System, the Ion Chef System for automated library and template generation, as well as forensically relevant Precision ID panels for mtDNA analysis. The Precision ID mtDNA panels give forensic DNA laboratories the ability to detect variation within noncoding control region sequences using as little as 2 pg of DNA.

The end to end solution also includes the Applied Biosystems Converge Software NGS Data Analysis module, which automates mitochondrial DNA analysis by leveraging optimized base calling, phylogenetically guided alignment and quality filtering algorithms.

'The Precision ID System for mtDNA analysis offers excellent sensitivity for both sample quality and quantity,' said Rosy Lee, vice president and general manager of Human Identification for Thermo Fisher Scientific. 'Traditional methods for mtDNA analysis can be time-consuming and expensive. With the NDIS approval of Precision ID System, forensic scientists can now maximize the potential of this forensic genetic marker.'

Learn more at www.thermofisher.com/hid-ngs

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billionand approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands - Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services - we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Media Contact
Mauricio Minotta
Director, Public Relations
+1 760 929 2456
Mauricio.minotta@thermofisher.com

SOURCE Thermo Fisher Scientific

Disclaimer

Thermo Fisher Scientific Inc. published this content on 09 July 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 July 2019 12:17:02 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on THERMO FISHER SCIENTIFIC
10:42aTHERMO FISHER SCIENTIFIC : New Handheld Analyzer Uses Laser-Induced Breakdown Sp..
AQ
08/19THERMO FISHER SCIENTIFIC : New Handheld Analyzer Uses Laser-Induced Breakdown Sp..
PU
08/14THERMO FISHER SCIENTIFIC : Introduces Scalable Solution for Optical Fault Isolat..
PU
08/07THERMO FISHER SCIENTIFIC : Automation-Compatible Prepared Culture Media Plate Te..
AQ
08/07THERMO FISHER SCIENTIFIC : New Instrument for Automated Antimicrobial Susceptibi..
AQ
08/07THERMO FISHER SCIENTIFIC : New Blood Tests Help Assess Asthma Risk and Decide Pe..
AQ
08/06THERMO FISHER SCIENTIFIC : New Instrument for Automated Antimicrobial Susceptibi..
PU
08/06THERMO FISHER SCIENTIFIC : New Blood Tests Help Assess Asthma Risk and Decide Pe..
PU
08/06THERMO FISHER SCIENTIFIC : Showcases New Innovations for the Clinic During AACC ..
PU
08/06THERMO FISHER SCIENTIFIC : New Expanded Analytical Instrument Portfolio of U.S. ..
PU
More news
Financials (USD)
Sales 2019 25 442 M
EBIT 2019 5 988 M
Net income 2019 3 775 M
Debt 2019 13 946 M
Yield 2019 0,27%
P/E ratio 2019 30,1x
P/E ratio 2020 28,7x
EV / Sales2019 4,95x
EV / Sales2020 4,57x
Capitalization 112 B
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Average target price 309,56  $
Last Close Price 279,52  $
Spread / Highest target 19,8%
Spread / Average Target 10,7%
Spread / Lowest Target -18,1%
EPS Revisions
Managers
NameTitle
Marc N. Casper President, Chief Executive Officer & Director
Jim P. Manzi Chairman
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Stephen Williamson Chief Financial Officer & Senior Vice President
Joseph C. Beery Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
THERMO FISHER SCIENTIFIC24.90%111 941
DANAHER CORPORATION37.42%101 658
BOSTON SCIENTIFIC CORPORATION19.27%59 536
INTUITIVE SURGICAL3.46%57 108
EDWARDS LIFESCIENCES CORPORATION43.20%46 273
ILLUMINA, INC.-4.59%42 432